Kimberly-ClarkKMBEarnings & Financial Report
Kimberly-Clark Corporation is an American multinational consumer goods and personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.
Revenue
$4.9B
Gross Profit
$1.7B
Operating Profit
$548.0M
Net Profit
$447.0M
Gross Margin
34.0%
Operating Margin
11.1%
Net Margin
9.1%
YoY Growth
-0.8%
EPS
$1.34
Kimberly-Clark Q4 FY2024 Financial Summary
Kimberly-Clark reported revenue of $4.9B (down 0.8% YoY) for Q4 FY2024, with a net profit of $447.0M (down 12.2% YoY) (9.1% margin). Cost of goods sold was $3.3B, operating expenses totaled $1.1B.
Key Financial Metrics
| Total Revenue | $4.9B |
|---|---|
| Net Profit | $447.0M |
| Gross Margin | 34.0% |
| Operating Margin | 11.1% |
| Report Period | Q4 FY2024 |
Kimberly-Clark Annual Revenue by Year
Kimberly-Clark annual revenue history includes year-by-year totals (for example, 2025 revenue was $16.4B).
| Year | Annual Revenue |
|---|---|
| 2025 | $16.4B |
| 2024 | $20.1B |
| 2023 | $20.4B |
| 2022 | $20.2B |
Kimberly-Clark Quarterly Revenue & Net Profit History
Kimberly-Clark results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $4.2B | +2.7% | $675.0M | 16.2% |
| Q4 FY2025 | $3.3B | -33.2% | $499.0M | 15.1% |
| Q3 FY2025 | $4.2B | -16.2% | $446.0M | 10.7% |
| Q2 FY2025 | $4.2B | -17.2% | $509.0M | 12.2% |
| Q1 FY2025 | $4.8B | -6.0% | $567.0M | 11.7% |
| Q4 FY2024 | $4.9B | -0.8% | $447.0M | 9.1% |
| Q3 FY2024 | $5.0B | -3.5% | $907.0M | 18.3% |
| Q2 FY2024 | $5.0B | -2.0% | $544.0M | 10.8% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.03B | $4.95B | $4.93B | $4.84B | $4.16B | $4.15B | $3.29B | $4.16B |
| YoY Growth | -2.0% | -3.5% | -0.8% | -6.0% | -17.2% | -16.2% | -33.2% | 2.7% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $17.28B | $17.16B | $16.55B | $16.30B | $16.77B | $16.89B | $17.10B | $17.2M |
| Liabilities | $16.14B | $15.88B | $15.71B | $15.20B | $15.50B | $15.56B | $15.60B | $15.3M |
| Equity | $1.14B | $1.28B | $840.0M | $1.10B | $1.27B | $1.33B | $1.50B | $1.9M |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $1.02B | $958.0M | $817.0M | $327.0M | $770.0M | $708.0M | $972.0M |